The Director of Finance will develop, assess and maintain secure, effective and innovative finance and grants functions at BHI. As a direct report to the President & CEO, the Director of Finance influences the BHI organization through strategic decision making, which influences BHI operations decisions as BHI continues to add capacity. This position oversees and is supported by the Manager, Human Resources & Operations. The position is summarized as follows:
FINANCE
Analyze and present financial reports in an accurate and timely manner; present consolidated quarterly financial reports at Board of Directors meetings; oversee all financial, program and grants accounting.
Coordinate and lead the annual audit process, liaise with external auditors and the treasurer of the Board of Directors; assess any changes necessary.
Lead annual budgeting and planning process for parent organization and subsidiary; administer and review all financial plans and budgets; monitor progress and changes and keep Chief Executive Officer abreast of the organization’s financial status.
Manage organizational cash flow and forecasting.
Work with BHI’s accounting firm to file annual tax returns.
Ensure that the accounts receivable collection schedule is adhered to and that financial data and cash flow are steady and support operational requirements; update collection schedule based on changes in cash flow; and thank charitable contributors who have made payments.
Ensure that organizational financial obligations (i.e. salaries payable, invoices payable) are met in a timely
manner and that financial commitments fall in line with cash flow plan.
Update and implement accounting practices; improve the finance department’s overall policy and procedure manual.
Effectively communicate and present critical financial matters to the CEO and Board of Directors.
To apply, please send your resume, cover letter, and salary requirements to Amanda Hague at ahague@biohealthinnovation.org. No recruiter calls will be accepted.
With both Maryland and Virginia donating land and financing construction of new federal buildings, a hundred square mile District of Columbia (originally called Territory of Columbia) was surveyed.
University of Maryland (UM) Ventures announced today that the University of Maryland, Baltimore (UMB) has granted worldwide, exclusive licensing rights for a new vaccine technology to Serenta Biotechnology, LLC, a Gaithersburg, MD-based startup. The license is based on technology co-owned by UMB and Northern Arizona University and is the basis for a multivalent vaccine against infections caused by Staphylococcus aureus, a bacterial strain often resistant to antibiotics.
We are pleased to report that 20/20 placed first place among 21 pre-selected entrepreneurial contestants this month at the U.S. China Innovation & Investment Summit InnoSTARS competition in Houston, Texas: http://www.uschinainnovation.org/innostars/ . As a result, we have won an all-expenses paid trip to China to meet with and pitch to investors in that country as part of the Final Stage of the contest. The contest involved a 7-minute pitch by the CEO of 20/20 followed by Q&A before a panel of judges comprising Chinese and American VCs and business executives.
On April 26, hundreds of people came to East Baltimore for the grand opening of FastForward 1812. The event, billed as a celebration of a new physical space to support innovation, was just as much a celebration of the innovation hub’s promise to impact the future of Johns Hopkins, the city of Baltimore and people around the world by helping bring life-changing technologies to market.
“[This space is] a physical manifestation of our commitment to bringing together the necessary ingredients of innovation,” Johns Hopkins University President Ronald J. Daniels said during the celebration’s opening remarks.
Last year, Johns Hopkins University and MedImmune announced their collaboration on a unique new initiative, the Johns Hopkins-MedImmune Scholars Program. The program has just selected its first Ph.D. candidates for a curriculum that will prepare them for careers in the biopharma industry.
Inez Lam and Natalia Majewska, both first-year Johns Hopkins University Ph.D. students, will participate in the five-year program, the first-of-its-kind in the United States, to gain a better understanding of the process and challenges of drug discovery and development. Upon completion, they will receive a traditional Ph.D. from The Johns Hopkins University.
Maryland Technology Development Corp. is offering $300,000 to the person or organization that comes up with the best idea for how to support and grow technology companies in the state.
Are you an NIH-funded investigator focused on medical device innovations? NIH recently announced the availability of administrative supplements to parent awards for a number of different activity codes with participation by four ICs (see lists below). Both SBIR/STTR awardees as well as recipients of a number of different research grants are eligible.
Max Becton and Fairleigh Dickinson were two travelling salesmen when they met through an act of kindness in a Texas railroad station in 1897. The friendship that resulted formed the basis of a partnership that built Becton-Dickinson into a global medical technology company based in Bergen County. A story in 201 Magazine recounts the history of how the company got started.
As an entrepreneur, I spent over three years in two different startup incubators – Brazil’s Genesis Institute, part of PUC-Rio’s university, and Maryland’s Rockville Innovation Center, run by Montgomery County’s Economic Development Department. As mentor, I have also had the opportunity to coach several incubated companies, from incubators like 1776 and beyond. I could experience firsthand the benefits of business incubation, which can be significant for early-stage entrepreneurs.
For more than a decade, Indianapolis-based Lumina Foundation has been making grants to organizations that support its mission of increasing the number of adults obtaining postsecondary credentials.
That’s the typical playbook for private foundations—contribute to other not-for-profits that are trying to make a difference. But over the past year, Lumina has aggressively moved in a more novel direction, funneling more of its $1.2 billion endowment into venture capital. Instead of just handing out grants, it’s taking ownership stakes in for-profit businesses, mainly education-tech startups.
Entrepreneurs in healthcare and life science ventures must master the art of communication to all stakeholders in order to enhance their chance of success.Some of these skills are intuitive, some are learned, but all are essential in order to build a cohesive and collaborative team that will succeed in bringing your innovation to life! Join us at the next SoPE event and take home some pearls from the experts in this field.
This inaugural event will showcase technologies being developed at the National Cancer Institute (NCI) in Bethesda and Frederick, and Frederick National Laboratory for Cancer Research (FNLCR) to encourage startup formation, technology licensing, and collaborations. It will introduce the local scientific community to the regional technology development stakeholders and highlight available resources.
Prospective investors, established companies, interested stakeholders, and those looking to commercialize technologies are invited and encouraged to attend. The day will feature short technology summaries by NCI and FNLCR innovators, as well as presentations from regional stakeholders involved with technology development and commercialization. An interactive poster session by innovators and technology ambassadors will concurrently occur.
The Big Idea CONNECTpreneur Summer Forum Tysons Corner – June 13, 2017
“The Best Networking Event in the MidAtlantic.”
This will be our 24th consecutive SOLD OUT event over the last 6 years!
Over 70% of previous attendees surveyed say that CONNECTpreneur is the “Number One” tech and investor event in the Mid-Atlantic region!
DCInno calls CONNECTpreneur “The Best Networking Event in DC” and a “NETWORKING JACKPOT” of the Region’s TOP Entrepreneurs, Business Leaders, CXOs, Angels, and VCs.
This UNIQUE EVENT is like NONE OTHER in our region, because of the high quality of our attendees, speakers and presenters.
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
